polymerase chain reaction
Dec 15, 2022
BioGX’s ‘pixl’ Portable qPCR Platform; Stryker’s Citrefix Suture Anchor System; Boston Scientific to Acquire Majority Stake of Acotec Scientific; FDA Approved the Dexcom G7 CGM System; Agilent’s NSCLC Liquid Biopsy Companion Diagnostic Test Approval; ClearPoint Neuro’s Prism™ Neuro Laser Therapy
BioGX Announced Ex-US Commercial Launch of ‘pixl™’ Portable qPCR Platform On December 8, 2022, BioGX, a global provider of easy molecular diagnostic solutions, announced the Ex-US commercial release of BioGX's portable pixl™ qPCR real-time PCR platform for use with BioGX CE-IVD approved assays.&nbs...
Read More...
Nov 28, 2018
Researchers say CRISPR edits to a human embryo worked
The researchers announced that they had edited human embryos to repair a damaged gene that can lead to heart failure, but critics raised their eyebrows. Now, new evidence confirms that the gene editing was successful, said by reproductive and developmental biologist Shoukhrat Mitalipov of Oregon Health & Science...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
